BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29410961)

  • 1. The Diagnostic Roles of Cytokines in Hepatobiliary Cancers.
    Koca YS; Bulbul M; Barut I
    Biomed Res Int; 2017; 2017():2979307. PubMed ID: 29410961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum evaluation of soluble interferon-alpha/beta receptor and high-sensitivity C-reactive protein for diagnosis of the patients with gastrointestinal and hepatobiliary-pancreatic cancer.
    Miyake K; Imura S; Nishioka M; Batmunkh E; Sugimoto K; Ohmoto Y; Shimada M
    Cytokine; 2010 Mar; 49(3):251-5. PubMed ID: 19879773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical application of a new monoclonal antibody (19B7) against PIVKA-II in the diagnosis of hepatocellular carcinoma and pancreatobiliary malignancies.
    Nakao A; Taniguchi K; Inoue S; Takeda S; Harada A; Nonami T; Watanabe K; Takagi H
    Am J Gastroenterol; 1997 Jun; 92(6):1031-4. PubMed ID: 9177525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative and postoperative cytokines in patients with cancer.
    Nakazaki H
    Cancer; 1992 Aug; 70(3):709-13. PubMed ID: 1320454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic significance of alpha fetoprotein in carcinomas of liver and biliary tract - a comparative study from the western region of Nepal.
    Mittal A; Sathian B; Chandrashekharan N; Farooqui SM; Hussain A
    Asian Pac J Cancer Prev; 2011; 12(12):3475-8. PubMed ID: 22471500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum cytokine profiles predict survival benefits in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective cohort study.
    Hayashi T; Yamashita T; Terashima T; Suda T; Okada H; Asahina Y; Hayashi T; Hara Y; Nio K; Sunagozaka H; Takatori H; Arai K; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S
    BMC Cancer; 2017 Dec; 17(1):870. PubMed ID: 29258450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in inflammatory cytokine profiles after transarterial chemotherapy in patients with hepatocellular carcinoma.
    Kim MJ; Jang JW; Oh BS; Kwon JH; Chung KW; Jung HS; Jekarl DW; Lee S
    Cytokine; 2013 Nov; 64(2):516-22. PubMed ID: 24035756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of several cytokines and adhesion molecules in the diagnosis and prediction of survival of hepatocellular carcinoma.
    Iliaz R; Akyuz U; Tekin D; Serilmez M; Evirgen S; Cavus B; Soydinc H; Duranyildiz D; Karaca C; Demir K; Besisik F; Kaymakoglu S; Akyuz F
    Arab J Gastroenterol; 2016 Dec; 17(4):164-167. PubMed ID: 27916547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine evaluation in liver cirrhosis and hepatocellular carcinoma.
    Cheng KS; Tang HL; Chou FT; Chou JW; Hsu CH; Yu CJ; Kao ST; Li TC
    Hepatogastroenterology; 2009; 56(93):1105-10. PubMed ID: 19760951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine profile in Egyptian hepatitis C virus genotype-4 in relation to liver disease progression.
    Zekri AR; Ashour MS; Hassan A; Alam El-Din HM; El-Shehaby AM; Abu-Shady MA
    World J Gastroenterol; 2005 Nov; 11(42):6624-30. PubMed ID: 16425355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary sclerosing cholangitis is a premalignant condition].
    Schramm C; Galle PR
    Z Gastroenterol; 2005 Jun; 43(6):607-11. PubMed ID: 15986292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of cytokines in hepatitis C-related liver disease: a longitudinal study.
    Huang YS; Hwang SJ; Chan CY; Wu JC; Chao Y; Chang FY; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jun; 62(6):327-33. PubMed ID: 10389289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of relevant immune-modulators and cytokines in hepatocellular carcinoma and premalignant hepatic lesions.
    Zekri AN; El Deeb S; Bahnassy AA; Badr AM; Abdellateif MS; Esmat G; Salama H; Mohanad M; El-Dien AE; Rabah S; Abd Elkader A
    World J Gastroenterol; 2018 Mar; 24(11):1228-1238. PubMed ID: 29568203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased multimodality treatment options has improved survival for Hepatocellular carcinoma but poor survival for biliary tract cancers remains unchanged.
    Alabraba E; Joshi H; Bird N; Griffin R; Sturgess R; Stern N; Sieberhagen C; Cross T; Camenzuli A; Davis R; Evans J; O'Grady E; Palmer D; Diaz-Nieto R; Fenwick S; Poston G; Malik H
    Eur J Surg Oncol; 2019 Sep; 45(9):1660-1667. PubMed ID: 31014988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C.
    Aroucha DC; do Carmo RF; Moura P; Silva JL; Vasconcelos LR; Cavalcanti MS; Muniz MT; Aroucha ML; Siqueira ER; Cahú GG; Pereira LM; Coêlho MR
    Cytokine; 2013 Jun; 62(3):421-5. PubMed ID: 23602201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmented enhancement of in vitro production of inflammatory cytokines in peripheral blood mononuclear cells in patients undergoing simultaneous resection of the liver and gastrointestinal tract.
    Sasada K; Miyazaki M; Nakagawa K; Ito H; Ambiru S; Shimizu H; Nakajima N
    Crit Care Med; 1999 May; 27(5):929-36. PubMed ID: 10362415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An eight cytokine signature identified from peripheral blood serves as a fingerprint for hepatocellular cancer diagnosis.
    Shen J; Wu H; Peng N; Cai J
    Afr Health Sci; 2018 Jun; 18(2):260-266. PubMed ID: 30602951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and survival for hepatic, pancreatic and biliary cancers in England between 1998 and 2007.
    Coupland VH; Kocher HM; Berry DP; Allum W; Linklater KM; Konfortion J; Møller H; Davies EA
    Cancer Epidemiol; 2012 Aug; 36(4):e207-14. PubMed ID: 22534487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum biomarkers for early detection of hepatocellular carcinoma associated with HCV infection in egyptian patients.
    Zekri AR; Youssef AS; Bakr YM; Gabr RM; El-Rouby MN; Hammad I; Ahmed EA; Marzouk HA; Nabil MM; Hamed HA; Aly YH; Zachariah KS; Esmat G
    Asian Pac J Cancer Prev; 2015; 16(3):1281-7. PubMed ID: 25735368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study of angiogenic response to yttrium-90 radioembolization with resin microspheres.
    Carpizo DR; Gensure RH; Yu X; Gendel VM; Greene SJ; Moore DF; Jabbour SK; Nosher JL
    J Vasc Interv Radiol; 2014 Feb; 25(2):297-306.e1. PubMed ID: 24360887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.